Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era.

Expert review of molecular diagnostics - 1 Sept 2024

Testa Ugo

Abstract excerpt

INTRODUCTION: Primary liver cancer is a major health problem being the sixth most frequent cancer in the world and the third cause of cancer-related death in the world. The most common histological type of liver cancer is hepatocellular carcinoma (HCC, 75-80%). AREAS COVERED: Based on primary literature, this review provides an updated analysis of studies of genetic characterization of HCC at the level of gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Liver Neoplasms

Share to Molecular Targeted Therapy

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 39194003
DOI: 10.1080/14737159.2024.2392278

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era.PMID 39194003Read ↗

Clinical value of identifying genes that inhibit hepatocellular carcinomas.Semantic proximity Read ↗

Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges AheadSemantic proximity Read ↗

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinomaSemantic proximity Read ↗

Advances in targeted therapies for hepatocellular carcinoma in the genomic era.Semantic proximity Read ↗

Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent AdvancementsSemantic proximity Read ↗

Advances in molecular classification and precision oncology in hepatocellular carcinoma.Semantic proximity Read ↗

Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.Semantic proximity Read ↗

Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future DirectionsSemantic proximity Read ↗

Molecular subtyping of hepatocellular carcinoma: A step toward precision medicineSemantic proximity Read ↗

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.Semantic proximity Read ↗

Hepatocellular carcinoma: old friends and new tricksSemantic proximity Read ↗

Molecular perspectives for the treatment of hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.